Diabetes as a result of atypical anti-psychotic drugs - A report of three cases

Diabetic Medicine

Volumn 17, Issue 6, 2000, Pages 484-486

  Rigalleau, V ^a   Gatta, B ^a   Bonnaud, S ^b   Masson, M ^c   Bourgeois, M L ^c   Vergnot, V ^a   Gin, H ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b CENTRE HOSPITALIER DE LA CÔTE BASQUE   (France)

^c Serv Hospitalo Universitaire de P   (France)

Author keywords

Atypical anti psychotic; Clozapine; Diabetes; Olanzapine

Indexed keywords

CLOZAPINE; INSULIN; OLANZAPINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; INSULIN DEFICIENCY; KETOACIDOSIS; MALE; PSYCHOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DEPRESSIVE DISORDER; DIABETES MELLITUS; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PIRENZEPINE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 0033913283     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00296.x     Document Type: Article

References (13)

1. 1 Hippius H. A historical perspective of Clozapine. J Clin Psychiatry 1999; 60S: 22-23.
2. 2 Amsler HA, Teerenhovi L, Barth E. Agranulocytosis in patients treated with clozapine: a study of the Finnish epidemy. Acta Psychiatr Scand 1977; 56: 241-248.
3. 3 Kane J, Honigfeld G, Singer J, the Clozaril Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789-796.
4. 4 Lader M. Some adverse effects of antipsychotics. Prevention and treatment. J Clin Psychiatry 1999; 60S: 18-21.
5. 5 Wirshing DA, Wirshing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J et al. Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 1999; 60: 358-363.
6. 6 Wirshing DA, Spellberg BJ, Erhart SM, Marder SR, Wirshing WC. Novel antipsychotics and new onset diabetes. Biol Psychiatry 1998; 44: 778-783.
7. 7 Gatta B, Rigalleau V, Gin H. Diabetic ketoacidosis with olanzapine treatment. Diabetes Care 1999; 22: 1002-1003.
8. 8 Fertig MK, Brooks VG, Shelton PS, English CW. Hyperglycemia associated with olanzapine. J Clin Psychiatry 1998; 59: 687-689.
9. 9 Ober SK, Hudak R, Rusterholtz A. Hyperglycemia and olanzapine. Am J Psychiatry 1999; 156: 970.
10. 10 Colli A, Cocciolo M, Francobandiera G, Rogantin F, Cattalini N. Diabetic ketoacidosis associated with clozapine treatment. Diabetes Care 1999; 22: 176-177.
11. 11 Wozniak KM, Linnoila M. Hyperglycemic properties of serotonin receptor antagonists. Life Sci 1991; 49: 101-9.
12. 12 Peterson GA, Byrd SL. Diabetic ketoacidosis from clozapine and lithium cotreatment. Am J Psychiatry 1996; 153: 737-8.
13. 13 Zyprexa (olanzapine). In Physician's Desk Reference. Montvale, NJ: Medical Economics, 1998; 1512-1518.